Better outcome by shrinking radiation target for glioblastoma
Part of Cancer, Injuries & trauma clinical trials.
This trial tests a smaller radiation target for newly diagnosed glioblastoma to reduce side effects while keeping treatment effective. It may help patients who are healthy enough for standard chemoradiotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with glioblastoma for the first time.
- You are well enough to do daily activities (WHO performance status 0-2).
- Your cancer team has recommended chemoradiotherapy.
- You are not in another competing trial.
- You can have an MRI scan (no medical reasons against it).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
This trial tests a shorter, more intense course of radiation therapy (hypofractionated radiotherapy) for people with newly diagnosed glioblastoma who have had surgery. The goal is to see if this approach is safe and works well for treating the tumor.
This trial is testing an escalated dose of proton beam radiation, along with standard chemotherapy and MRI-guided planning, for newly diagnosed glioblastoma. It aims to see whether the higher radiation dose can improve treatment while staying safe for nearby critical brain structures.
This trial compares two ways of giving radiation—standard photon radiotherapy (IMRT) versus proton beam therapy—for people with glioblastoma. It may help find a safer or more effective radiation approach for shrinking tumors and improving outcomes.
This trial tests putting radiation directly into the brain right after surgery for glioblastoma, instead of waiting for standard radiation later. It aims to see if this approach works better and is safe for you.
This trial tests a type of radiation therapy that uses a smaller, more focused area on the brain after surgery for glioblastoma. The goal is to see if this approach can reduce side effects while still controlling the tumor.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.